Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Institut Curie
With
AstraZeneca
Gustave Roussy, Cancer Campus, Grand Paris
An estimated 20-65% of women treated with breast surgery for breast cancer experience chronic pain in the treated breast. Patients will be randomize between: infiltration with chlorhydrate of ropivacaine at the time of breast surgery for cancer versus placebo.Intra-operative analgesia will be standardized as well as peri-operative pain management.
Age
18–85
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Breast cancer patients treated by conservative surgery with axillary node dissection or treated by mastectomy with or without axillary node dissection or sentinel lymph node biopsy.
ASA physical status 1, 2 or 3
With a minimum life expectancy of 2 years
Written informed consent
You may not be if
Any previous cancer other than breast cancer
Allergies to local anesthesic and morphine
Reported history of drug
Pregnancy
Homolateral breast surgery during the last 3 years
Analgesic use pre-operatively
Renal, pulmonary or liver major dysfunction
Active malignant disease
Unable to follow the protocol for any reason
Clareo Health | Chlorhydrate of Ropivacaine and Breast Cancer Surgery
